HEALTH● LOW1h ago · Oct 24, 2026, 2:10 PM
Eli Lilly releases promising early-stage data on ADC for ovarian cancer
Seeking Alpha Tech · global
Eli Lilly has released encouraging early-stage data regarding an Antibody-Drug Conjugate (ADC) for treating ovarian cancer. This research offers promising potential for future cancer therapies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoVanessa Trump says she is cancer-free six months after revealing diagnosisBBC WorldHEALTH1h agoInsurance-driven health care threatens public health system, warns KSSP seminarThe HinduHEALTH2h agoChennai hospital organises pink walk to raise breast cancer awarenessThe HinduHEALTH2h agoCSI Chennai Diocese organises anti-drug run in cityThe Hindu